How Does Type 1 Diabetes Develop?
暂无分享,去创建一个
D. Accili | J. Bluestone | M. Atkinson | P. Arvan | K. Herold | G. Eisenbarth | M. Hebrok | M. V. von Herrath | C. Rhodes | D. Markel | M. Pietropaolo
[1] J. Bollyky,et al. Short-term IL-1beta blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes. , 2010, Clinical immunology.
[2] M. Prentki,et al. Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass , 2010, Diabetologia.
[3] P. Marrack,et al. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register , 2010, Proceedings of the National Academy of Sciences.
[4] P. Santamaria,et al. The long and winding road to understanding and conquering type 1 diabetes. , 2010, Immunity.
[5] M. Andersen,et al. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. , 2010, Toxicology and applied pharmacology.
[6] Jeffrey A. Bluestone,et al. Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.
[7] E. Unanue,et al. In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans , 2010, Nature Immunology.
[8] M. J. MacDonald,et al. Regulation of insulin secretion: role of mitochondrial signalling , 2010, Diabetologia.
[9] Nichole Reisdorph,et al. Chromogranin A is an autoantigen in type 1 diabetes , 2010, Nature Immunology.
[10] M. Donath,et al. Blockade of interleukin 1 in type 1 diabetes mellitus , 2010, Nature Reviews Endocrinology.
[11] M. Peakman,et al. Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes , 2010, Nature Reviews Immunology.
[12] S. Bonner-Weir,et al. Dimorphic histopathology of long-standing childhood-onset diabetes , 2010, Diabetologia.
[13] R. Bottino,et al. Long‐Term Controlled Normoglycemia in Diabetic Non‐Human Primates After Transplantation with hCD46 Transgenic Porcine Islets , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] Darrell M. Wilson,et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. , 2009, The New England journal of medicine.
[15] L. Harrison,et al. Reappraising the stereotypes of diabetes in the modern diabetogenic environment , 2009, Nature Reviews Endocrinology.
[16] P. Gottlieb,et al. The honeymoon phase: intersection of metabolism and immunology , 2009, Current opinion in endocrinology, diabetes, and obesity.
[17] K. Herold,et al. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage. , 2009, Endocrinology and metabolism clinics of North America.
[18] A. Bhushan,et al. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.
[19] A. Tarakhovsky,et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. , 2009, Genes & development.
[20] M. Foss,et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.
[21] H. Thomas,et al. Beta cell apoptosis in diabetes , 2009, Apoptosis.
[22] R. Bottino,et al. Recovery of Endogenous β-Cell Function in Nonhuman Primates After Chemical Diabetes Induction and Islet Transplantation , 2009, Diabetes.
[23] A. Tengholm,et al. Oscillatory control of insulin secretion , 2009, Molecular and Cellular Endocrinology.
[24] M. Redondo,et al. Concordance for islet autoimmunity among monozygotic twins. , 2008, The New England journal of medicine.
[25] Johnny Ludvigsson,et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.
[26] R. Rizza,et al. β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.
[27] R. Mirmira. Faculty Opinions recommendation of Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. , 2008 .
[28] R. Scharfmann,et al. β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.
[29] R. Robertson,et al. Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .
[30] R. Robertson,et al. Glucolipotoxicity: fuel excess and beta-cell dysfunction. , 2008, Endocrine reviews.
[31] B. Wicksteed,et al. The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead? , 2007, Diabetes, obesity & metabolism.
[32] U. Boggi,et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.
[33] S. Malozowski,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[34] D. Accili,et al. Metabolic Diapause in Pancreatic β-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1* , 2007, Journal of Biological Chemistry.
[35] A. Purcell,et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. , 2006, The Journal of clinical investigation.
[36] William W Kwok,et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. , 2006, The Journal of clinical investigation.
[37] Michel Goldman,et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.
[38] G. Eisenbarth,et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.
[39] D. Serreze,et al. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice , 2005, Immunological reviews.
[40] I. Chang,et al. Death effectors of β-cell apoptosis in type 1 diabetes , 2004 .
[41] R. Hardman,et al. Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus , 1987, Diabetologia.
[42] I. Chang,et al. Death effectors of beta-cell apoptosis in type 1 diabetes. , 2004, Molecular genetics and metabolism.
[43] Jerrold M. Olefsky,et al. Diabetes mellitus : a fundamental and clinical text , 2004 .
[44] M. Atkinson,et al. Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination. , 2003, Diabetes care.
[45] J. Killestein. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.
[46] D. D’Alessio,et al. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. , 2002, Diabetes.
[47] M. Atkinson,et al. Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.
[48] H. Thomas,et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. , 2000, Diabetes.
[49] M. Prentki,et al. Metabolic control of -cell function , 2000 .
[50] Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. , 1998, Annals of internal medicine.
[51] M. Hammami. Diabetes Mellitus: A Fundamental and Clinical Text , 1997 .
[52] M. Mcdaniel,et al. A role for nitric oxide and other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunction and destruction. , 1997, Advances in experimental medicine and biology.
[53] S. Lenzen,et al. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.
[54] C. Newgard,et al. Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.
[55] M. V. von Herrath,et al. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. , 1994, Immunity.
[56] K. Yamagata,et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. , 1993, The Journal of clinical investigation.
[57] R. Thirlby,et al. Severe Diabetes Induced in Subtotally Depancreatized Dogs by Sustained Hyperglycemia , 1988, Diabetes.
[58] G. Bottazzo. Death of a Beta Cell: Homicide or Suicide? , 1986, Diabetic medicine : a journal of the British Diabetic Association.
[59] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.
[60] J. P. Moulin,et al. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. , 1982, Metabolism: clinical and experimental.
[61] H. Okamoto,et al. Translational control of proinsulin synthesis by glucose , 1980, Nature.
[62] C. J. Hedeskov,et al. The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation. , 1975, The Biochemical journal.